卡普拉珠单抗治疗先天性血栓性血小板减少性紫癜。
Caplacizumab for congenital thrombotic thrombocytopenic purpura.
机构信息
Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
出版信息
Am J Hematol. 2022 Nov;97(11):E420-E421. doi: 10.1002/ajh.26693. Epub 2022 Sep 8.
PMID:36054034
Abstract
Caplacizumab rapidly increased platelet count which likely shorted the hospital stay and reduced plasma transfusion requirement.
摘要
卡普拉西珠单抗迅速增加血小板计数，可能缩短了住院时间，减少了血浆输注需求。
Zotero 插件